Skip to content
E-MAIL US:info@curegp.org
Sign In / Register
0 items - $0.00 Checkout
Gastroparesis: Fighting for Change, Advocating for a Cure
  • Home
  • About Us
  • About Gastroparesis
  • Faces of GP
  • Events
    • GASTROPARESIS AWARENESS MONTH 2022 GIVEAWAY 2!
  • Resources
    • Videos
      • What Reasearchers Should Know About Gastroparesis
      • Interviews
        • Ask an Expert
        • Ostomies
    • Blogs
  • Campaigns
    • Gastroparesis 2023 Awareness Campaign – #GPFullLife4Me
    • GASTROPARESIS AWARENESS MONTH 2022
    • Proclamations – August 2022
    • Demand Recognition
    • Previous Campaigns
      • Gastroparesis Awareness Month 2021 Project
      • #DCGreen2019
      • Legislation
        • S. 464 / H.R. 2163 (Safe Step Act)
      • Proclamations
      • Gastroparesis Awareness 2019
        • Proclamations
        • #RealGP
        • Virtual Advocacy Day
      • Holiday Giveaway!
      • Proclamations – August 2020
      • Surveys
        • Mental Health Survey
        • Statistics Survey
        • Symptoms Survey
  • Store
    • View My Cart
    • My Account
Gastroparesis: Fighting For Change > 2022 > August > 01

Day: August 1, 2022

Kelly Sharp

Posted on August 1, 2022August 4, 2022 by Gastroparesis: Fighting For Change
Christopher

My son Christopher runs feeds at night. I’m grateful for the option to provide him nutrition. He’s a warrior.

Loading spinner
Posted in GP Stories Leave a comment

Login

  • Don't have an account? Signup Now »
  • Lost your password?

Language

Recent Posts

  • GASTROPARESIS AWARENESS MONTH 2023 GIVEAWAY !
  • Gastroparesis 2023 Awareness Campaign – #GPFullLife4Me
  • GASTROPARESIS AWARENESS MONTH 2022 GIVEAWAY 2!
  • GASTROPARESIS AWARENESS MONTH 2022 GIVEAWAY!
  • Kelly Sharp

Social Media Feed


Gastroparesis: Fighting for Change

11/20/26

Gastroparesis: Fighting for Change

www.medicaldaily.com/fda-gastric-stimulator-shortage-enterra-gastroparesis-481443

… See MoreSee Less

Gastric stimulators used for severe gastroparesis are now in FDA shortage status, with Enterra II unavailable and the unapproved Enterra Ascent allowed to fill the gap.

www.medicaldaily.com

The FDA expects a shortage of implantable gastric stimulators through late 2027 after component shortages halted Enterra II production, affecting patients awaiting implants or battery replacements.

View on Facebook

·
Share



Share on Facebook



Share on Twitter



Share on Linked In



Share by Email

Gastroparesis: Fighting for Change

11/20/26

Gastroparesis: Fighting for Change

“’To develop better treatments, we first need to understand how the healthy stomach works and, just as importantly, what happens to those cells when disease strikes,’ said Rajan Singh, Ph.D., assistant professor of research in the Department of Physiology and Cell Biology…Using genetic models, physiological measurements, single-cell analyses and human tissue samples, Singh and his collaborators will investigate three key questions: how macrophages influence gastric motility, how they affect the gastrointestinal barrier and whether abnormal macrophage states can be reprogrammed to improve disease processes…‘Our goal is to understand how these macrophages change in disease, what those changes do to the stomach and ultimately whether we can intervene,’ Singh said. ‘If we understand the mechanism, we can begin asking whether those changes can be prevented or reversed… Gastroparesis will not be solved by looking at one cell type or one measurement in isolation,’ Singh said. ‘The opportunity now is to understand how these cellular systems interact at the neuroimmune axis and use that knowledge to move toward treatments directed at the biology present in individual patients.’If successful, the project could identify biomarkers of macrophage dysfunction and reveal biological pathways that may eventually become targets for new therapies. ‘Science rarely advances in a single leap,’ Singh said. ‘This award reflects years of experiments, setbacks, collaboration, mentorship and persistence, and an early institutional investment that gave the idea room to grow.’”

… See MoreSee Less

From seed funding to NIH R01 grant

www.unr.edu

Springboard research support helped Rajan Singh, Ph.D., advance his work on gut-resident macrophages into his first NIH R01-funded research program

View on Facebook

·
Share



Share on Facebook



Share on Twitter



Share on Linked In



Share by Email

Gastroparesis: Fighting for Change
updated their status.

11/19/26

Gastroparesis: Fighting for Change
This content isn’t available right now

When this happens, it’s usually because the owner only shared it with a small group of people, changed who can see it or it’s been deleted.

View on Facebook

·
Share



Share on Facebook



Share on Twitter



Share on Linked In



Share by Email

Gastroparesis: Fighting for Change
updated their status.

11/19/26

Gastroparesis: Fighting for Change
This content isn’t available right now

When this happens, it’s usually because the owner only shared it with a small group of people, changed who can see it or it’s been deleted.

View on Facebook

·
Share



Share on Facebook



Share on Twitter



Share on Linked In



Share by Email

Gastroparesis: Fighting for Change

11/17/26

Gastroparesis: Fighting for Change

Reminder: Happening now!

… See MoreSee Less

This content isn’t available right now

When this happens, it’s usually because the owner only shared it with a small group of people, changed who can see it or it’s been deleted.

View on Facebook

·
Share



Share on Facebook



Share on Twitter



Share on Linked In



Share by Email

Gastroparesis: Fighting for Change
updated their status.

11/16/26

Gastroparesis: Fighting for Change
This content isn’t available right now

When this happens, it’s usually because the owner only shared it with a small group of people, changed who can see it or it’s been deleted.

View on Facebook

·
Share



Share on Facebook



Share on Twitter



Share on Linked In



Share by Email

Gastroparesis: Fighting for Change

11/11/26

Gastroparesis: Fighting for Change


Photos

View on Facebook

·
Share



Share on Facebook



Share on Twitter



Share on Linked In



Share by Email

Gastroparesis: Fighting for Change

11/06/26

Gastroparesis: Fighting for Change

Though the authors frame this as a helpful tool to remove "patient burden," I see this as a monitoring device designed to require "proof" of illness – because patients, of course, cannot be believed. Isn’t that a real concern here?Medical policing. I am not on board."Preliminary findings suggest audio-based technologies may provide an objective approach to detecting vomiting and retching, with future automation needed to support scalable implementation…In conclusion, this exploratory study supports the feasibility of audio-based detection of retch and expulsion events in patients with gastroparesis and provides preliminary evidence of convergent validity." Opinions?

… See MoreSee Less

Evaluation of an audio-based monitoring system for detecting retching and vomiting in gastroparesis: an observational cohort study – npj Gut and Liver

www.nature.com

This study evaluated a novel, audio-based digital monitoring system for detecting retching and vomiting (expulsion) events in a noninterventional, longitudinal study in 25 participants with gastropare…

View on Facebook

·
Share



Share on Facebook



Share on Twitter



Share on Linked In



Share by Email

Gastroparesis: Fighting for Change

11/06/26

Gastroparesis: Fighting for Change

Enterra Gastric Stimulator Update:To better serve patients, the FDA will permit distribution and implantation of the stimulator (without penalties for doctors or the manufacturer) under an enforcement discretion policy. So, although it has not yet been granted formal approval, patients may still access the device. Standard protocols and safety measures will still apply.Please consult your physician for further information about scheduling this procedure.

… See MoreSee Less


Photos

View on Facebook

·
Share



Share on Facebook



Share on Twitter



Share on Linked In



Share by Email

Gastroparesis: Fighting for Change

11/05/26

Gastroparesis: Fighting for Change

"In one of my first actions as Acting Commissioner, I convened a roundtable of rare disease advocates to familiarize myself with the concerns of the rare disease community. I did so because I firmly believe there is nothing more vital than ensuring those who often feel unheard are given a clear voice."This was a necessary and welcome move. You should be commended. But please know that there are many underrecognized and underserved communities that also must be heard. #Gastroparesis patients have only one FDA-approved medication: Reglan/Gimoti, which comes with a black-box warning. The Domperidone Expanded Access Program ended in 2024, leaving patients whose lives were greatly improved by this medication with no safe, effective alternatives. No novel medications have been approved in more than 45 years. We must have a voice!#CureGPU.S. Food and Drug Administration

… See MoreSee Less

Delivering Answers and Hope for Rare Disease Families

www.fda.gov

Rare diseases present our most formidable challenge and our greatest opportunity to speed life-saving treatments and cures to the patients who need them most.

View on Facebook

·
Share



Share on Facebook



Share on Twitter



Share on Linked In



Share by Email

Copyright by Gastroparesis: Fighting For Change, LLC in 2019

P.O. Box 712, Morrisville, PA 19067

  • Home
  • Privacy Policy